The expression of NANOG and OCT4 was evaluated by immunohistochemistry in 122 cases, SOX2 in 121 cases, Nestin in 93 cases and PDPN in 85 cases in which representative tumor tissue was available. This evidence concerns the gene SOX2 and neoplasm.